Issue 4/2016
Breast Cancer Issue
Content (14 Articles)
PI3K/AKT/mTOR: role in breast cancer progression, drug resistance, and treatment
Angel Guerrero-Zotano, Ingrid A. Mayer, Carlos L. Arteaga
Patient-derived xenograft (PDX) models in basic and translational breast cancer research
Lacey E. Dobrolecki, Susie D. Airhart, Denis G. Alferez, Samuel Aparicio, Fariba Behbod, Mohamed Bentires-Alj, Cathrin Brisken, Carol J. Bult, Shirong Cai, Robert B. Clarke, Heidi Dowst, Matthew J. Ellis, Eva Gonzalez-Suarez, Richard D. Iggo, Peter Kabos, Shunqiang Li, Geoffrey J. Lindeman, Elisabetta Marangoni, Aaron McCoy, Funda Meric-Bernstam, Helen Piwnica-Worms, Marie-France Poupon, Jorge Reis-Filho, Carol A. Sartorius, Valentina Scabia, George Sflomos, Yizheng Tu, François Vaillant, Jane E. Visvader, Alana Welm, Max S. Wicha, Michael T. Lewis
The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer
Jennifer L. Hsu, Mien-Chie Hung
One microenvironment does not fit all: heterogeneity beyond cancer cells
Ik Sun Kim, Xiang H.-F. Zhang
EMT, cell plasticity and metastasis
Christine L. Chaffer, Beatriz P. San Juan, Elgene Lim, Robert A. Weinberg
From transformation to metastasis: deconstructing the extracellular matrix in breast cancer
Shelly Kaushik, Michael W Pickup, Valerie M Weaver
Cancer-derived extracellular vesicles: the ‘soil conditioner’ in breast cancer metastasis?
Andrew R. Chin, Shizhen Emily Wang